AUS
NZ
UK
CA
USA
IND
Highlights:
- Zoetis specializes in the development and commercialization of animal health medicines, vaccines, and diagnostic products.
- The company serves both the livestock and companion animal markets across multiple regions.
- Financial metrics reflect a strong presence in the animal health sector with a well-structured market approach.
Zoetis (NYSE:ZTS) operates in the animal health industry, offering a broad portfolio of medicines, vaccines, and diagnostic solutions for livestock and companion animals. The company develops and manufactures products that contribute to the well-being of various species, supporting both agricultural and veterinary markets worldwide.
Stock Performance and Market Standing
The company's stock price has remained active within a consistent range over the past year. The market capitalization places Zoetis among leading companies in the animal health sector.
The price-to-earnings ratio aligns with industry trends, while the beta value indicates relative stability compared to broader market fluctuations. Moving averages reflect the stock’s position within its trading patterns.
Financial Structure and Liquidity
Zoetis maintains a structured financial approach, as reflected in its debt-to-equity ratio. The current and quick ratios highlight the company's approach to short-term liquidity management, ensuring operational stability while maintaining a diverse product portfolio.
Industry Presence and Market Reach
With a strong international presence, Zoetis continues to expand its role in the global animal health market. The company’s diverse product portfolio and broad customer base reinforce its position in the industry.
